Skip to NavigationSkip to content

Business Services

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

Published on: 21/12/20

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed Professor Akiko Iwasaki to its Scientific Advisory Board (SAB).

Professor Iwasaki is currently the Waldemar Von Zedwitz Professor in the Department of Immunology and a Professor in the Department of Molecular, Cellular and Developmental Biology at Yale University, where her team is studying immune responses to influenza in the lungs and the herpes simplex virus in the genital tract.

Ionis founder Stanley T Crooke to retire

Published on: 18/12/20

Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of directors effective June 2021.

Sage Therapeutics appoints Barry Greene as CEO

Published on: 18/12/20

Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene as Chief Executive Officer in a move to accelerate the company’s growth and leverage the talents of the leaders in the brain health space.

Top Ten most popular articles on Pharmafile.com this week

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the virus has been identified in the UK, extra doses found in vials of the Pfizer vaccine have boosted the US’ supply, and researchers have said that a quarter of the global population may not be vaccinated until 2022.

Meanwhile, a number of treatments have secured recommendation or approval, including Janssen's esketamine nasal spray for patients with major depressive disorder, and Novartis' Beovu for wet age-related macular degeneration.

Samsung Biologics names John Rim as CEO and President

Published on: 17/12/20

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the company's board of directors meeting yesterday.

How COVID-19 is affecting diabetics and their access to insulin in America

Published on 15/12/20 at 11:45am

Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor Kavanagh analyses what specific factors are making the COVID-19 pandemic particularly deadly for diabetics.

PPAs - Ready to make a long-term commitment to zero carbon?

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve its sustainability goals as the deadline for net zero edges closer.

For those looking to accelerate their renewable energy goals, Power Purchase Agreements (PPA) are a viable option and will help pharma businesses match their long-term horizons.

PPAs - Ready to make a long-term commitment to zero carbon?

Published date: 
15/12/2020
Summary: 
For those looking to accelerate their renewable energy goals, Power Purchase Agreements (PPA) are a viable option and will help pharma businesses match their long-term horizons.

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve its sustainability goals as the deadline for net zero edges closer.

For those looking to accelerate their renewable energy goals, Power Purchase Agreements (PPA) are a viable option and will help pharma businesses match their long-term horizons.

Top Ten most popular articles on Pharmafile.com this week

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine candidates continues to dominate. The Pfizer/BioNTech vaccine continues to lead the pack, having been approved for emergency use in the UK earlier this week. However, experts have warned that the therapy could cause an allergic reaction in some patients, while the candidate has even attracted the attention of hacker groups. 

Check out the week's ten most popular articles on Pharmafile.com now!

Pharmafile.com's weekly COVID-19 news round-up

Image credit: CDC

COVID-19 vaccine news continues to roll in and continues to be positive, with AstraZeneca now releasing Phase 3 data that proves its vaccine candidate is safe and effective. Vaccinations began this week in the UK with Pfizer and BioNTech's candidate after it secured emergency approval. However, despite all this good news, tech firm IBM says it has identified attempts by potentially state-sponsored hackers to compromise these new vaccination efforts. 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches